Related Experiment Videos
Neuropeptides and Alzheimer's disease
1Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710.
Journal of the American Geriatrics Society
|August 1, 1990
Summary
Neuropeptides, crucial for brain function, show altered levels in neuropsychiatric disorders. This review focuses on neuropeptide roles in Alzheimer's disease pathogenesis, examining neurodegenerative changes.
Area of Science:
- Neuroscience
- Molecular Biology
- Neuropathology
Background:
- Neuropeptides function as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system.
- Alterations in neuropeptide levels are implicated in neuropsychiatric disorders like schizophrenia and affective disorders.
- Alzheimer's disease, a common neurodegenerative disorder, is characterized by neurofibrillary tangles and senile plaques.
Purpose of the Study:
- To review recent advances in neuropeptide biology.
- To focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease.
Main Methods:
- Review of existing literature on neuropeptide biology and Alzheimer's disease.
- Analysis of postmortem studies investigating neuropeptide alterations in Alzheimer's disease.
Main Results:
- Evidence suggests pathological alterations in neuropeptide-containing neurons in Alzheimer's disease.
- Neuropeptides are increasingly recognized for their potential involvement in neurodegenerative processes.
Conclusions:
- Neuropeptides are significant in central nervous system function and neuropsychiatric disorders.
- Further research into neuropeptides is crucial for understanding and potentially treating Alzheimer's disease.